Nuvation Bio NUVB Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -105%+234pp | -338.7%+532pp | -871%+694pp | -1,564.9%+4,198pp | -5,762.8%— | |
| Net margin | -102.1%+223pp | -325.3%+488pp | -813.1%+600pp | -1,413.4%+4,121pp | -5,534.2%— | |
| Returns | ||||||
| Return on equity | -39.5%+13.7pp | -53.2%-0.7pp | -52.5%+11.9pp | -64.4%+55.3pp | -119.7%-13.4pp | |
| Return on invested capital | -47.4%+19.6pp | -67%-6.4pp | -60.6%+46.3pp | -106.9%+26.6pp | -133.5%-15.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×+0.1× | 0.1×+0.1× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Liquidity | ||||||
| Current ratio | 7.4×+0.5× | 7×-1.5× | 8.5×-0.9× | 9.4×+0.4× | 9×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×+0.1× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $0.85-5.4% | $0.90-6.0% | $0.95-13.0% | $1.09-11.7% | $1.24-28.2% | |
| Valuation | ||||||
| Market capitalization | $1.49B-51.5% | $3.07B+143% | $1.27B+81.6% | $697.54M+17.0% | $596.07M-33.4% | |
| Price / sales | 10.4×-38.4× | 48.8×+1.5× | 47.3×-1.2× | 48.6×-5.8× | 54.4×— | |
| Price / book | 4.7×-5.4× | 10×+6.2× | 3.9×+2.0× | 1.9×+0.4× | 1.4×-0.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nuvation Bio's profit margins?
- Nuvation Bio (NUVB) runs a 54.3% gross margin and a -105.0% operating margin, with a -102.1% net margin.
- Where do Nuvation Bio's ratios come from?
- Every ratio is computed from Nuvation Bio's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.